Health Canada approves phase 2a Covid-19 trial of NuvOx’s oxygen therapeutic

This article was originally published here

Some patients with AHRF can progress to a more severe form of the disease called acute respiratory distress syndrome (ARDS). ARDS, which is associated with lung inflammation leading

The post Health Canada approves phase 2a Covid-19 trial of NuvOx’s oxygen therapeutic appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply